Patents by Inventor Caroline Colin

Caroline Colin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240103019
    Abstract: Glycosylphosphatidylinositol (GPI) is a glycolipid that anchors more than 150 proteins to the cell surface. Pathogenic variants in several genes that participate in GPI biosynthesis cause inherited GPI deficiency (IGD) disorders. Here, the inventors reported that homozygous null alleles of PIGG, a gene involved in GPI modification, are responsible for the rare Emm-negative blood phenotype. Using a panel of K562 cells defective in both the GPI-transamidase and GPI remodeling pathways, they demonstrate that the Emm antigen, whose molecular basis has remained unknown for decades, is carried only by free GPI and that its epitope is composed of the second and third ethanolamine of the GPI backbone. Importantly, the inventors show that the decrease in Emm expression in several IGD patients is indicative of GPI defects. Overall, our findings establish Emm as a novel blood group system and have important implications for understanding the biological function of human free GPI.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 28, 2024
    Inventors: Thierry PEYRARD, Slim AZOUZI, Oliver HERMINE, Yves COLIN-ARONOVICZ, Romain DUVAL, Caroline LE VAN KIM
  • Patent number: D1011909
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: January 23, 2024
    Assignee: The Procter & Gamble Company
    Inventors: U-Ping Loh, Yun Qin Lee, Caroline Colin